Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 12 August 2020
Accepted: 19 January 2021
First Online: 30 January 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: E.W. serves on the speaker’s bureau for Allergan Plc, Melinta Therapeutics, and Astellas Pharma and on the advisory board for GenMark Diagnostics and Shionogi. All other authors declare that they have no competing interests.